Nanjing University of Chinese Medicine Reports Findings in Non- Alcoholic Fatty L iver Disease (Combined structure-based virtual screening and machine learning ap proach for the identification of potential dual inhibitors of ACC and DGAT2)

Robotics & Machine Learning Daily News2024，Issue(Aug.16) ：77-78.

来源：

NETL
NSTL

Nanjing University of Chinese Medicine Reports Findings in Non- Alcoholic Fatty L iver Disease (Combined structure-based virtual screening and machine learning ap proach for the identification of potential dual inhibitors of ACC and DGAT2)

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Liver Diseases and Con ditions - Non-Alcoholic Fatty Liver Diseaseis the subject of a report. Accordin g to news reporting originating in Nanjing, People’s Republic ofChina, by NewsR x journalists, research stated, “Acetyl-coenzyme A carboxylase (ACC) and diacylg lycerolacyltransferase 2 (DGAT2) are recognized as potential therapeutic target s for nonalcoholic fatty liverdisease (NAFLD). Inhibitors targeting ACC and DGA T2 have exhibited the capacity to reduce hepatic fatin individuals afflicted wi th NAFLD.”

Key words

Nanjing/People’s Republic of China/Asi a/Cyborgs/Drugs and Therapies/Emerging Technologies/Health and Medicine/Liv er Diseases and Conditions/Machine Learning/Non-Alcoholic Fatty Liver Disease/Pharmaceuticals

引用本文复制引用

出版年

2024

Robotics & Machine Learning Daily News

ISSN：

段落导航